26 research outputs found
Rab27a controls HIV-1 assembly by regulating plasma membrane levels of phosphatidylinositol 4,5-bisphosphate
During the late stages of the HIV-1 replication cycle, the viral polyprotein Pr55Gag is recruited to the plasma membrane (PM), where it binds phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and directs HIV-1 assembly. We show that Rab27a controls the trafficking of late endosomes carrying phosphatidylinositol 4-kinase type 2 α (PI4KIIα) toward the PM of CD4+ T cells. Hence, Rab27a promotes high levels of PM phosphatidylinositol 4-phosphate and the localized production of PI(4,5)P2, therefore controlling Pr55Gag membrane association. Rab27a also controls PI(4,5)P2 levels at the virus-containing compartments of macrophages. By screening Rab27a effectors, we identified that Slp2a, Slp3, and Slac2b are required for the association of Pr55Gag with the PM and that Slp2a cooperates with Rab27a in the recruitment of PI4KIIα to the PM. We conclude that by directing the trafficking of PI4KIIα-positive endosomes toward the PM, Rab27a controls PI(4,5)P2 production and, consequently, HIV-1 replication.Fil: Pereyra Gerber, Federico PehuĂ©n. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida; ArgentinaFil: Cabrini, Mercedes. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida; ArgentinaFil: Jancic, Carolina Cristina. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Paoletti, Luciana Elisa. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Centro CientĂfico TecnolĂłgico Conicet - Rosario. Instituto de BiologĂa Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias BioquĂmicas y FarmacĂ©uticas. Instituto de BiologĂa Molecular y Celular de Rosario; ArgentinaFil: Banchio, Claudia Elena. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Centro CientĂfico TecnolĂłgico Conicet - Rosario. Instituto de BiologĂa Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias BioquĂmicas y FarmacĂ©uticas. Instituto de BiologĂa Molecular y Celular de Rosario; ArgentinaFil: Von Bilderling, Catalina. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Ciudad Universitaria. Instituto de FĂsica de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de FĂsica de Buenos Aires; ArgentinaFil: Sigaut, Lorena. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Centro de MicroscopĂas Avanzadas; Argentina. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Pietrasanta, Lia. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Centro de MicroscopĂas Avanzadas; Argentina. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas; ArgentinaFil: Duette, Gabriel. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida; ArgentinaFil: Freed, Eric O.. National Cancer Institute at Frederick; Estados UnidosFil: Basile, Genevieve de Saint. Institut National de la SantĂ© et de la Recherche MĂ©dicale; FranciaFil: Moita, Catarina Ferreira. Instituto Gulbenkian de Ciencia; PortugalFil: Moita, Luis Ferreira. Instituto Gulbenkian de Ciencia; PortugalFil: Amigorena, Sebastian. Institute Curie; FranciaFil: Benaroch, Philippe. Institute Curie; FranciaFil: Geffner, Jorge RaĂșl. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida; ArgentinaFil: Ostrowski, Matias. Consejo Nacional de Investigaciones CientĂficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Houssay. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones BiomĂ©dicas en Retrovirus y Sida; Argentin
Massively HIV-1-infected macrophages exhibit a severely hampered ability to differentiate into osteoclasts
IntroductionOsteoclasts play a crucial role in bone resorption, and impairment of their differentiation can have significant implications for bone density, especially in individuals with HIV who may be at risk of altered bone health. The present study aimed to investigate the effects of HIV infection on osteoclast differentiation using primary human monocyte-derived macrophages as precursors. The study focused on assessing the impact of HIV infection on cellular adhesion, cathepsin K expression, resorptive activity, cytokine production, expression of co-receptors, and transcriptional regulation of key factors involved in osteoclastogenesis.MethodsPrimary human monocyte-derived macrophages were utilized as precursors for osteoclast differentiation. These precursors were infected with HIV, and the effects of different inoculum sizes and kinetics of viral replication were analyzed. Subsequently, osteoclastogenesis was evaluated by measuring cellular adhesion, cathepsin K expression, and resorptive activity. Furthermore, cytokine production was assessed by monitoring the production of IL-1ÎČ, RANK-L, and osteoclasts. The expression levels of co-receptors CCR5, CD9, and CD81 were measured before and after infection with HIV. The transcriptional levels of key factors for osteoclastogenesis (RANK, NFATc1, and DC-STAMP) were examined following HIV infection.ResultsRapid, massive, and productive HIV infection severely impaired osteoclast differentiation, leading to compromised cellular adhesion, cathepsin K expression, and resorptive activity. HIV infection resulted in an earlier production of IL-1ÎČ concurrent with RANK-L, thereby suppressing osteoclast production. Infection with a high inoculum of HIV increased the expression of the co-receptor CCR5, as well as the tetraspanins CD9 and CD81, which correlated with deficient osteoclastogenesis. Massive HIV infection of osteoclast precursors affected the transcriptional levels of key factors involved in osteoclastogenesis, including RANK, NFATc1, and DC-STAMP.ConclusionsThe effects of HIV infection on osteoclast precursors were found to be dependent on the size of the inoculum and the kinetics of viral replication. These findings underscore the importance of understanding the underlying mechanisms to develop novel strategies for the prevention and treatment of bone disorders in individuals with HIV
Candida albicans delays HIV-1 replication in macrophages.
Macrophages are one of the most important HIV-1 target cells. Unlike CD4(+) T cells, macrophages are resistant to the cytophatic effect of HIV-1. They are able to produce and harbor the virus for long periods acting as a viral reservoir. Candida albicans (CA) is a commensal fungus that colonizes the portals of HIV-1 entry, such as the vagina and the rectum, and becomes an aggressive pathogen in AIDS patients. In this study, we analyzed the ability of CA to modulate the course of HIV-1 infection in human monocyte-derived macrophages. We found that CA abrogated HIV-1 replication in macrophages when it was evaluated 7 days after virus inoculation. A similar inhibitory effect was observed in monocyte-derived dendritic cells. The analysis of the mechanisms responsible for the inhibition of HIV-1 production in macrophages revealed that CA efficiently sequesters HIV-1 particles avoiding its infectivity. Moreover, by acting on macrophages themselves, CA diminishes their permissibility to HIV-1 infection by reducing the expression of CD4, enhancing the production of the CCR5-interacting chemokines CCL3/MIP-1α, CCL4/MIP-1ÎČ, and CCL5/RANTES, and stimulating the production of interferon-α and the restriction factors APOBEC3G, APOBEC3F, and tetherin. Interestingly, abrogation of HIV-1 replication was overcome when the infection of macrophages was evaluated 2-3 weeks after virus inoculation. However, this reactivation of HIV-1 infection could be silenced by CA when added periodically to HIV-1-challenged macrophages. The induction of a silent HIV-1 infection in macrophages at the periphery, where cells are continuously confronted with CA, might help HIV-1 to evade the immune response and to promote resistance to antiretroviral therapy
Epithelial cells activate plasmacytoid dendritic cells improving their anti-HIV activity.
Plasmacytoid dendritic cells (pDCs) play a major role in anti-viral immunity by virtue of their ability to produce high amounts of type I interferons (IFNs) and a variety of inflammatory cytokines and chemokines in response to viral infections. Since recent studies have established that pDCs accumulate at the site of virus entry in the mucosa, here we analyzed whether epithelial cells were able to modulate the function of pDCs. We found that the epithelial cell lines HT-29 and Caco-2, as well as a primary culture of human renal tubular epithelial cells (HRTEC), induced the phenotypic maturation of pDCs stimulating the production of inflammatory cytokines. By contrast, epithelial cells did not induce any change in the phenotype of conventional or myeloid DCs (cDCs) while significantly stimulated the production of the anti-inflammatory cytokine IL-10. Activation of pDCs by epithelial cells was prevented by Bafilomycin A1, an inhibitor of endosomal acidification as well as by the addition of RNase to the culture medium, suggesting the participation of endosomal TLRs. Interestingly, the cross-talk between both cell populations was shown to be associated to an increased expression of TLR7 and TLR9 by pDCs and the production of LL37 by epithelial cells, an antimicrobial peptide able to bind and transport extracellular nucleic acids into the endosomal compartments. Interestingly, epithelium-activated pDCs impaired the establishment of a productive HIV infection in two susceptible target cells through the stimulation of the production of type I IFNs, highlighting the anti-viral efficiency of this novel activation pathway
Extracellular vesicles from human plasma dampen inflammation and promote tissue repair functions in macrophages
Abstract Although inflammation is a vital defence response to infection, if left uncontrolled, it can lead to pathology. Macrophages are critical players both in driving the inflammatory response and in the subsequent events required for restoring tissue homeostasis. Extracellular vesicles (EVs) are membraneâenclosed structures released by cells that mediate intercellular communication and are present in all biological fluids, including blood. Herein, we show that extracellular vesicles from plasma (pEVs) play a relevant role in the control of inflammation by counteracting PAMPâinduced macrophage activation. Indeed, pEVâtreatment of macrophages simultaneously with or prior to PAMP exposure reduced the secretion of proâinflammatory ILâ6 and TNFâα and increased ILâ10 response. This antiâinflammatory activity was associated with the promotion of tissueârepair functions in macrophages, characterized by augmented efferocytosis and proâangiogenic capacity, and increased expression of VEGFa, CD300e, RGS2 and CD93, genes involved in cell growth and tissue remodelling. We also show that simultaneous stimulation of macrophages with a PAMP and pEVs promoted COX2 expression and CREB phosphorylation as well as the accumulation of higher concentrations of PGE2 in cell culture supernatants. Remarkably, the antiâinflammatory activity of pEVs was abolished if cells were treated with a pharmacological inhibitor of COX2, indicating that pEVâmediated induction of COX2 is critical for the pEVâmediated inhibition of inflammation. Finally, we show that pEVs added to monocytes prior to their MâCSFâinduced differentiation to macrophages increased efferocytosis and diminished proâinflammatory cytokine responses to PAMP stimulation. In conclusion, our results suggest that pEVs are endogenous homeostatic modulators of macrophages, activating the PGE2/CREB pathway, decreasing the production of inflammatory cytokines and promoting tissue repair functions
Epithelial cells induce the phenotypic maturation of pDCs in a cell contact-dependent manner.
<p>Experiments were performed using 24-transwell chambers with a polycarbonate filter (0.2 ”m pore size). HT-29 cells were grown to confluence on the filter. pDCs (3Ă10<sup>5</sup>) were cultured alone in the lower chamber or in contact with the monolayer of epithelial cells, in the upper chamber. Control cells were cultured in the upper chamber without epithelial cells. After 12 h of culture, pDCs were harvested and the expression of HLA-DR, CD83, CD86, and MHC class I was analyzed in the gate of CD123<sup>+</sup> cells by flow cytometry. The relative mean fluorescence intensity (MFI) of isotype controls were in all cases lower than 5 (not shown). The MFI for control cells (for all the markers analyzed) was assigned to the value of 100, and the MFI for pDCs cultured alone in the lower chamber (X) or those cultured in contact with the monolayer of epithelial cells in the upper chamber (Y) was calculated using the equation: X or YĂ100/MFI of control pDCs. Histograms show a representative experiment (nâ=â4â8). Graph bars show the MFI of HLA-DR, CD83, CD86, and MHC class I in the gate of CD123<sup>+</sup> cells. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0028709#s2" target="_blank">Results</a> are the mean ± SEM of 6â7 experiments. (* p<0.05 vs control).</p
Autophagy Mediates Interleukin-1ÎČ Secretion in Human Neutrophils
Interleukin-1ÎČ (IL-1ÎČ), a major pro-inflammatory cytokine, is a leaderless cytosolic protein whose secretion does not follow the classical endoplasmic reticulum-to-Golgi pathway, and for which a canonical mechanism of secretion remains to be established. Neutrophils are essential players against bacterial and fungi infections. These cells are rapidly and massively recruited from the circulation into infected tissues and, beyond of displaying an impressive arsenal of toxic weapons effective to kill pathogens, are also an important source of IL-1ÎČ in infectious conditions. Here, we analyzed if an unconventional secretory autophagy mechanism is involved in the exportation of IL-1ÎČ by these cells. Our findings indicated that inhibition of autophagy with 3-methyladenine and Wortmannin markedly reduced IL-1ÎČ secretion induced by LPSâ+âATP, as did the disruption of the autophagic flux with Bafilomycin A1 and E64d. These compounds did not noticeable affect neutrophil viability ruling out that the effects on IL-1ÎČ secretion were due to cell death. Furthermore, VPS34IN-1, a specific autophagy inhibitor, was still able to reduce IL-1ÎČ secretion when added after it was synthesized. Moreover, siRNA-mediated knockdown of ATG5 markedly reduced IL-1ÎČ secretion in neutrophil-differentiated PLB985 cells. Upon LPSâ+âATP stimulation, IL-1ÎČ was incorporated to an autophagic compartment, as was revealed by its colocalization with LC3B by confocal microscopy. Overlapping of IL-1ÎČ-LC3B in a vesicular compartment peaked before IL-1ÎČ increased in culture supernatants. On the other hand, stimulation of autophagy by cell starvation augmented the colocalization of IL-1ÎČ and LC3B and then promoted neutrophil IL-1ÎČ secretion. In addition, specific ELISAs indicated that although both IL-1ÎČ and pro-IL-1ÎČ are released to culture supernatants upon neutrophil stimulation, autophagy only promotes IL-1ÎČ secretion. Furthermore, the serine proteases inhibitor AEBSF reduced IL-1ÎČ secretion. Moreover, IL-1ÎČ could be also found colocalizing with elastase, suggesting both some vesicles containing IL-1ÎČ intersect azurophil granules content and that serine proteases also regulate IL-1ÎČ secretion. Altogether, our findings indicate that an unconventional autophagy-mediated secretory pathway mediates IL-1ÎČ secretion in human neutrophils
Primary human renal tubular epithelial cells (HRTEC) induce the activation of pDCs.
<p>Primary human renal proximal tubular cells, obtained as described under <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0028709#s4" target="_blank">Materials and Methods</a>, were grown to confluence in 96 well, flat bottom plates. pDCs (1Ă10<sup>5</sup>/well) were cultured for 12 h alone (controls), with confluent HRTEC, or with supernatants collected from confluent HRTEC incubated alone for 12 h. Then, the phenotype of pDCs in the gate of CD123+ cells was analyzed by flow (A) Histograms of representative experiments (nâ=â6) are shown. The MFI of isotype controls were in all cases lower than 5 (not shown). Graph bars show the relative mean fluorescence intensity (MFI) of HLA-DR, CD83, and CD80 for pDCs cultured alone or in the presence of epithelial cells or epithelial cell supernatants. The MFI of pDCs cultured alone is assigned the value of 100. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0028709#s2" target="_blank">Results</a> are the mean ± SEM of 7â8 experiments performed in duplicate. (* p<0.05 vs pDCs). (B) The production of TNF-α, IL-6, and IL-1ÎČ were assessed in cell supernatants by ELISA. *p<0.05 vs pDCs.</p
<i>Candida albicans</i> stimulates the production of the retroviral host-restriction factors APOBEC3G, APOBEC3F, tetherin, and interferon-α.
<p>(<b>A</b> and <b>B</b>) Macrophages (5x10<sup>5</sup>/0.5 ml) were cultured for 2 h in the absence or presence of CA using a macrophage: CA ratio of 1:10. Cells were then washed and cultured for an additional period of 18 h. Then, the presence of APOBEC3F and APOBEC3G was evaluated by quantitative PCR (relativized to the expression of GAPDH mRNA), the expression of tetherin (Bst-2) analyzed by flow cytometry, and the amount of IFN-α quantified in cell supernatants by ELISA. (<b>C</b>) Macrophages (5x10<sup>5</sup>/0.5 ml) were cultured with HIV-1<sub>BaL</sub> (50 ng p24/ml) in the absence or presence of CA (macrophage: CA ratio of 1:10). Then, cells were washed and incubated with or without saturating concentrations of a blocking monoclonal antibody directed to the receptor for type I IFNs. The production of HIV-1 was evaluated at day 7 post-infection. In (<b>A</b>), representative experiments are shown (4,5). Bars represent the arithmetic means ± SEM of 5 experiments. (A and B) *p<0.05 vs M. (<b>C</b>) *p<0.05 vs M or M+CA+anti-IFNR.</p